These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25055169)

  • 1. Cannabis use and transition to psychosis in people at ultra-high risk.
    Valmaggia LR; Day FL; Jones C; Bissoli S; Pugh C; Hall D; Bhattacharyya S; Howes O; Stone J; Fusar-Poli P; Byrne M; McGuire PK
    Psychol Med; 2014 Sep; 44(12):2503-12. PubMed ID: 25055169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
    McHugh MJ; McGorry PD; Yung AR; Lin A; Wood SJ; Hartmann JA; Nelson B
    Psychol Med; 2017 Mar; 47(4):616-626. PubMed ID: 27821204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
    Kraan T; Velthorst E; Koenders L; Zwaart K; Ising HK; van den Berg D; de Haan L; van der Gaag M
    Psychol Med; 2016 Mar; 46(4):673-81. PubMed ID: 26568030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cannabis use in subjects at ultra high risk for psychosis].
    Fekih-Romdhane F; Hakiri A; Fadhel SB; Cheour M
    Presse Med; 2019 Nov; 48(11 Pt 1):1229-1236. PubMed ID: 31732360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.
    Carney R; Cotter J; Firth J; Bradshaw T; Yung AR
    Acta Psychiatr Scand; 2017 Jul; 136(1):5-15. PubMed ID: 28168698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis induced psychosis and subsequent psychiatric disorders.
    Shah D; Chand P; Bandawar M; Benegal V; Murthy P
    Asian J Psychiatr; 2017 Dec; 30():180-184. PubMed ID: 29096386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.
    Leeson VC; Harrison I; Ron MA; Barnes TR; Joyce EM
    Schizophr Bull; 2012 Jun; 38(4):873-80. PubMed ID: 21389110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition to Schizophrenia Spectrum Disorder Following Emergency Department Visits Due to Substance Use With and Without Psychosis.
    Myran DT; Harrison LD; Pugliese M; Solmi M; Anderson KK; Fiedorowicz JG; Perlman CM; Webber C; Finkelstein Y; Tanuseputro P
    JAMA Psychiatry; 2023 Nov; 80(11):1169-1174. PubMed ID: 37755727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.
    Andrade C
    J Clin Psychiatry; 2016 Jun; 77(6):e739-42. PubMed ID: 27337422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
    Seddon JL; Birchwood M; Copello A; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Sharma V; Marshall M; Singh SP
    Schizophr Bull; 2016 May; 42(3):619-25. PubMed ID: 26536902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study.
    Mechelli A; Riecher-Rössler A; Meisenzahl EM; Tognin S; Wood SJ; Borgwardt SJ; Koutsouleris N; Yung AR; Stone JM; Phillips LJ; McGorry PD; Valli I; Velakoulis D; Woolley J; Pantelis C; McGuire P
    Arch Gen Psychiatry; 2011 May; 68(5):489-95. PubMed ID: 21536978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cannabis use on incidence of psychosis in people at clinical high risk.
    Chester LA; Valmaggia LR; Kempton MJ; Chesney E; Oliver D; Hedges EP; Klatsa E; Stahl D; van der Gaag M; de Haan L; Nelson B; McGorry P; Amminger GP; Riecher-Rössler A; Studerus E; Bressan R; Barrantes-Vidal N; Krebs MO; Glenthøj B; Nordentoft M; Ruhrmann S; Sachs G; McGuire P;
    Psychiatry Clin Neurosci; 2023 Sep; 77(9):469-477. PubMed ID: 37070555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cannabis and psychosis].
    Curtis L; Rey-Bellet P; Merlo MC
    Rev Med Suisse; 2006 Sep; 2(79):2099-100, 2102-3. PubMed ID: 17073176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.
    Marconi A; Di Forti M; Lewis CM; Murray RM; Vassos E
    Schizophr Bull; 2016 Sep; 42(5):1262-9. PubMed ID: 26884547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study.
    Thompson A; Nelson B; Bechdolf A; Chanen AM; Domingues I; McDougall E; Yung AR
    Early Interv Psychiatry; 2012 Aug; 6(3):247-55. PubMed ID: 22672502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.